Stroke and Excitotoxicity Protection Excitotoxicity protection appeared in stroke models where bilateral carotid artery clamping produces ischemia-reperfusion injury with massive glutamate release
Common signs include extreme tiredness, low energy, pins and needles, muscle weakness, disturbed vision, low mood, diffuse hair loss and even premature greying
Its important to have realistic expectations and attend all treatment sessions
Since a 1mL syringe has 100 units, a 250mcg dose would be 10 units
Store in a secure laboratory environment Keep sealed until required for research use Protect from light and moisture Avoid repeated environmental exposure Handle and dispose of the material using appropriate laboratory procedures Laboratory Research Use Only SLU-PP-332 supplied by D&L Peptides is intended strictly for laboratory research use only
The procedure is quick and generally well-tolerated